Authors: Winblad, B Carfagna, N Bonura, L

Citation: B. Winblad et al., Nicergoline in dementia: a review of its pharmacological properties and therapeutic potential (vol 14, pg 267, 2000), CNS DRUGS, 15(1), 2001, pp. 58-58

Authors: Winblad, B Carfagna, N Bonura, L Rossini, BM Wong, EHF Battaglia, A

Citation: B. Winblad et al., Nicergoline in dementia - A review of its pharmacological properties and therapeutic potential, CNS DRUGS, 14(4), 2000, pp. 267-287

Authors: Wong, EHF Sonders, MS Amara, SG Tinholt, PM Piercey, MFP Hoffmann, WP Hyslop, DK Franklin, S Porsolt, RD Bonsignori, A Carfagna, N McArthur, RA

Citation: Ehf. Wong et al., Reboxetine: A pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor, BIOL PSYCHI, 47(9), 2000, pp. 818-829

Authors: Sortino, MA Battaglia, A Pamparana, F Carfagna, N Post, C Canonico, PL

Citation: Ma. Sortino et al., Neuroprotective effects of nicergoline in immortalized neurons, EUR J PHARM, 368(2-3), 1999, pp. 285-290

Authors: Caputi, A Di Luca, M Pastorino, L Colciaghi, F Carfagna, N Wong, E Post, C Cattabeni, F

Citation: A. Caputi et al., Nicergoline and its metabolite induce translocation of PKC isoforms in selective rat brain areas, NEUROSC R C, 23(3), 1998, pp. 159-167